Form 4: Director Dana G. Mead Jr. Receives RSU Grant at Inspire

Director Dana G. Mead Jr. was granted 3,562 restricted stock units (RSUs) by Inspire Medical Systems, Inc. on April 30, 2026.

Summary

• Director Dana G. Mead Jr. acquired 3,562 restricted stock units (RSUs) of Inspire Medical Systems, Inc. (INSP).
• The transaction occurred on April 30, 2026, at a price of $0 per share as part of an equity incentive award.
• Following this transaction, the director's total beneficial ownership of common stock increased to 26,213 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.

Positives

• The grant of RSUs aligns the director's interests with those of shareholders by providing equity-based compensation.

Negatives

• None identified; this is a standard equity compensation disclosure for a director.

Risks

• Vesting of the RSUs is contingent upon the director's continued service with the issuer through the vesting date.

Future Outlook

The RSUs are scheduled to vest on the earlier of the first anniversary of the grant date or the date immediately prior to a Change of Control, subject to continued service.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices intended to incentivize long-term oversight and alignment with shareholder value in the medical device sector.

Comparison to Industry Standards

• The use of RSUs as a component of director compensation is consistent with standard practices for mid-cap medical technology companies.
• The vesting schedule of one year is typical for director equity awards in the healthcare industry.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Vesting of the 3,562 RSUs on April 30, 2027, or upon a Change of Control.

Key Dates

Keywords

Inspire Medical Systems, INSP, Form 4, Insider Trading, Restricted Stock Units, Director Compensation